The Weill Cornell Medicine Registry and Biobank of Critically Ill Patients (WCM BoCI) for the Study of the Biology of Critical Illness is an ongoing registry that collects demographic and clinical information, and blood specimens from patients admitted into the medical intensive care unit (MICU) (IRB #1405015116). All adults (age 18 and older) admitted to the MICU are considered for enrollment. The presence of any of the following excludes a patient from study enrollment:1) Subjects with mental handicaps. 2) Subjects who are unable to provide consent directly and for whom an appropriate legal representative cannot be found to provide consent. 3) Subjects who have previously indicated that they do not wish to be enrolled in this study, (e.g. during a prior admission to the MICU). 4) Subjects admitted to the MICU purely to facilitate comfort care and weaning of medical intervention at end of life. 5) Subjects who are Jehovah's witnesses or are otherwise unable or unwilling to receive blood transfusions during hospitalization. 6) Subjects with a hemoglobin level of less than 7 g/dL upon admission to the MICU or subjects with rare blood groups, or other antigens that might require minimization of blood draws. 7) Patients with active bleeding at the time of MICU admission with hemoglobin levels less than 8 g/dL and subjects suffering from acute myocardial infarction with hemoglobin levels less than 8 g/dL.
Plasma DNA size distribution:
Although it has been reported that the size peak of plasma DNA is ~166-167 bp (1) (2) (3) , by our optimized method, we found there are also a proportion of plasma DNA with small fragment length. 19.05% plasma DNA was shorter than 100 bp by our optimized method, but only 1.77% by the standard method (Table S1 ). These small DNA fragments were overlooked in previous studies. The plasma DNA size distribution of each individual in this study is shown in Fig S2. mtDNA existed as small fragments (< 50 bp) in each individual. 
